XI'AN,
China, April 21, 2022 /PRNewswire/ -- Bon Natural
Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the
leading bio-ingredient solutions providers in the natural, health
and personal care industries, today announced that it has
successfully developed new nutraceutical compounds – Glucoraphanin
("GF") and Sulforaphane ("SFN"), both of which are compounds
extracted from cruciferous vegetables that could potentially
provide immunity support and improve certain other regulatory
health functions. The Company plans to launch GF and SFN based
consumer products in the next six months.
According to a recent study led by John Hopkins University and
published by Nature, both compounds are shown potential effect in
inhibiting the infection of SARS-CoV-2, including Delta and Omicron
(Source: Ordonez, A.A., Bullen, C.K., Villabona-Rueda, A.F. et al.
Sulforaphane exhibits antiviral activity against pandemic
SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in
mice. Commun Biol 5, 242 (2022).). BON has achieved cutting-edge
technological breakthroughs in developing such products, including
developing a proprietary GF separation platform and various GF
based health supplement consumer products with long shelf life and
building a high-efficiency SFN production line with proprietary
technology to reduce gastrointestinal irritation. In addition, BON
also plants the highest concentration cruciferous vegetables farm
to improve the large-scale production.
The Company plans to introduce the following health supplement
products within the next six months via multiple sales channels,
including direct sales to pharmacies and enterprise clients,
e-commerce platforms and distributors. These products likely
include:
- Immune system booster in soft gel capsules;
- Digestive health booster in soft gel capsules;
- Weight loss management products;
- Sleep aid products for mid-aged and elderly.
"This marks another major milestone in our strategy to introduce
proprietary products into new consumer markets", said Mr.
Richard Hu, CEO and Chairman of BON.
"Thanks to the tremendous and decade-long efforts of our R&D
team, we are excited and proud to be able to add health products
that are new and innovative to our nutraceutical line on the solid
foundation of our legacy compound business. In nearly all regions
of the world, the population aged 65 and older is growing faster
than the total population, challenging health companies and
organizations worldwide. We look forward to bringing our products
to the market and are optimistic about the market opportunity and
revenue potential from our broccoli extracted nutraceutical
products."
About Bon Natural Life Limited
The Company focuses on the manufacturing of personal care
ingredients, such as plant extracted fragrance compounds for
perfume and fragrance manufacturers, natural health supplements
such as powder drinks and bioactive food ingredient products mostly
used as food additives and nutritional supplements by their
customers. For additional information, please visit the Company's
website at www.bnlus.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may, "will, "intend," "should," "believe," "expect," "anticipate,"
"project," "estimate" or similar expressions that do not relate
solely to historical matters, it is making forward-looking
statements. Forward-looking statements are not guarantees of future
performance and involve risks and uncertainties that may cause the
actual results to differ materially from the Company's expectations
discussed in the forward-looking statements. These statements are
subject to uncertainties and risks including, but not limited to,
the following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the natural, health and personal care market
in China and the other international markets the Company
plans to serve; reputation and brand; the impact of competition and
pricing; government regulations; fluctuations in general economic
and business conditions in China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC. For these reasons, among
others, investors are cautioned not to place undue reliance upon
any forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward–looking
statements to reflect events or circumstances that arise after the
date hereof.
View original
content:https://www.prnewswire.com/news-releases/bon-natural-life-limited-adds-new-multi-functional-health-supplements-to-product-line-301529697.html
SOURCE Bon Natural Life Limited